Old drug, new hope: darifenacin trial targets ALS nerve damage
Disease control
Recruiting now
This study tests whether darifenacin, a drug already used for other conditions, can help people with ALS. The drug aims to support nerve-muscle connections that break down in ALS. Thirty adults with ALS will take either darifenacin or a placebo daily for 24 weeks to check safety …
Phase: PHASE2 • Sponsor: Oliver Blanchard • Aim: Disease control
Last updated May 26, 2026 04:35 UTC